Javelin Parp Medley: Avelumab Plus Talazoparib In Locally Advanced Or Metastatic Solid Tumors
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Avelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or Metastatic Solid Tumors
Interventions: DRUG: Avelumab Phase 1b|DRUG: Talazoparib Phase 1b|DRUG: Avelumab Phase 2|DRUG: Talazoparib Phase 2
Sponsor: Pfizer